| HOME  | PRODUCTS  | COMPANY  | TECHNICAL DOCS  | CONTACT US  |     
USA/Canada:+1 (248) 436-8085    

Mitochondrial Function monitoring - Prizmatix
 MitoViewer MV-2 A

    
A new Optical device for the assessment of Mitochondrial Function using NADH Fluorescence in-vivo

Why to Evaluate Mitochondrial Function?


 
Most of the ATP produced in the cells is synthesized by the mitochondria under aerobic conditions. The efficacy of ATP production is almost 20:1 when oxygen is available. Therefore, monitoring of mitochondrial function will provide direct information on the energy balance in the tissue. The MitoViewer is the ultimate device that enables the monitoring of mitochondrial function, in experimental animals, in vivo.

Why to measure Mitochondrial NADH?


 
Three enzymes of the respiratory chain are candidate for the evaluation of the oxidative phosphorylation process. Monitoring of Flavoproteins or Cytochrome aa3 redox state is not possible in blood perfused organs under in-vivo conditions due to various artifacts. Therefore NADH fluorescence signal is the best one to evaluate mitochondrial function in vivo.

NADH is a control marker in the energy generation process by the respiratory chain located in the mitochondria. NADH redox state is sensitive to the intracellular oxygen levels and to energy consumption by the tissue.

Principle of NADH monitoring


 
The tissue is excited by UV light (366 nm) passed via optical fiber to the monitoring site. Mitochondrial NADH (and not NAD+) absorbs the UV light and emits fluorescent light peaking at 450nm. The emitted light from the tissue at 450 nm (Fluorescence signal) and 366 nm (the Reflectance signal) is transferred to the fluorometer via other optical fibers. The changes in the reflected light are correlated to tissue blood volume and also serve to correct the NADH signal for hemodynamic artifacts. The reflected light and the NADH relative levels are displayed continuously in real time.

NADH monitoring

MitoViewer Main Features:

  • Could be used in various organs monitored during experimental animal models under In Vivo and In-Vvitro conditions.
  • Calculates corrected NADH (independent of hemodynamic changes in the tissue).
  • Measurement via flexible fiberoptic probe.
  • Custom types of probes can be supplied to best fit specific experimental setup.
  • Possible integration of the MitoViewer probe with other probes (for example Laser Doppler Flowmeter probe).

MitoViewer Applications:

  • Ischemia, Hypoxia, Anoxia, Heperoxia or Hypercapnia in various organs.
  • Activation of the brain by Cortical Spreading depression or Seizures.
  • Changing of heart metabolism by isotropic and chronotropic drugs.
  • Drug safety and efficacy monitored In-Vivo in various organs.

NADH monitoring

 

Typical responses of the mitochondrial function measured by the MitoViewer



Responses to Anoxia (100% nitrogen)
Typical responses of the brain to complete oxygen depletion by exposing the rat to 100% nitrogen. As can be seen, the Fluorescence signal (blue) is elevated due to inhibition of the respiratory chain activity while the Krebs cycle continues to produce NADH. The Reflected light signal (green) is decreasing, as expected under this condition, due to the elevation in blood volume in the monitored tissue. The corrected NADH signal (black) shows a symmetrical increase and decrease during the anoxic cycle.

NADH monitoring

Effects of an increase in energy consumption by the tissue
It was induced by exposure of the brain to Cortical Spreading Depression (by high level of potassium). In the normoxic brain the oxygen supply is not limited, and accordingly the Fluorescence signal (blue) and the NADH (red) decreased due to the oxidation of NADH. Under this condition the ATP turnover was dramatically increased and the extra oxygen supply was provided by an increase in microcirculatory blood flow. The same response was recorded in the kidney under mannitol infusion.

NADH monitoring

More info:


 
  MitoViewer MV-2 Brochure
  MitoViewer MV-2 User Manual

References


 
Chance, B. et al. Science 137: 499-508 (1962)
Mayevsky, A. and Chance, B. Brain Res. 98: 149-165 (1975)
Mayevsky, A. and Chance, B. Science 217: 537-540 (1982)
Mayevsky, A. Brain Res. Rev. 7: 49 68 (1984)
Mayevsky, A. and Chance, B. Mitochondrion 7: 330-339 (2007)
Mayevsky, A. and Rogatsky, G.G. Am. J. Physiol. Cell Physiol: 292: C615-C640 (2007)
Mayevsky, A. Mitochondrion 9: 165-179 (2009).
Mayevsky, A. and Barbiro-Michaely, E. Int. J. Biochem.Cell Biol: 41: 1977-1988 (2009)

© Prizmatix, Israel